Is the “3 by 5” Initiative the Best Approach to Tackling the HIV Pandemic?

Background to the debate: The World Health Organization (WHO) and its partners aim to treat 3 million people infected with HIV in poor and middle income countries with antiretroviral treatment by the end of 2005. The ambitious “3 by 5” initiative has had its supporters and its critics since its announcement in 2002.

[1]  China Tuberculosis Control Collaboration The effect of tuberculosis control in China , 2004, The Lancet.

[2]  J. Stephenson Report: HIV prevention efforts remain crucial as global treatment access expands. , 2004, Journal of the American Medical Association (JAMA).

[3]  T. Edejer,et al.  Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? , 2004, The Lancet.

[4]  J. Zarocostas WHO puts HIV/AIDS pandemic at top of its agenda , 2004, The Lancet.

[5]  Thomas R Frieden,et al.  Controlling tuberculosis in India. , 2002, The New England journal of medicine.

[6]  J. Sachs Macroeconomics and health: investing in health for economic development , 2002 .

[7]  Elizabeth Marum,et al.  Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century , 2002, The Lancet.

[8]  J. Fisher,et al.  First, do no harm: a call for emphasizing adherence and HIV prevention interventions in active antiretroviral therapy programs in the developing world. , 2002, AIDS.

[9]  Dorothy Bray,et al.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial , 1999, The Lancet.

[10]  R. Bayer Public health policy and the AIDS epidemic. An end to HIV exceptionalism? , 1991, The New England journal of medicine.

[11]  N. Michael,et al.  Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.

[12]  Shenglan Tang,et al.  The effect of tuberculosis control in China. Comment , 2004 .

[13]  Ilo Programme on Hiv HIV/AIDS and work : global estimates, impact and response , 2004 .

[14]  R. Feachem Commission on Macroeconomics and Health. , 2002, Bulletin of the World Health Organization.